The Centers for Disease Control and Preventions (CDC) Advisory Committee on Immunization Practices (ACIP) recently voted to update the 2023 child and adult immunization schedules, including “incorporating additional information for approved or authorized COVID-19 vaccines.” The ACIP did not make …
CDC Advisory Committee Updates Immunization Schedules Read more »
The U.S. Food and Drug Administration (FDA) recently amended the emergency use authorizations (EUAs) of the Pfizer-BioNTech and Moderna COVID-19 Vaccines “to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following …
Dr. Anthony S. Fauci recently announced that he will be stepping down in December from the positions of Director of the National Institute of Allergy and Infectious Diseases (NIAID), Chief of the NIAID Laboratory of Immunoregulation (where he also serves …
The U.S. Food & Drug Administration (FDA) recently “authorized the emergency use of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 through 17 years of age.” On …
Recent FDA Action & Publication Concerning COVID-19 Read more »
Recently, the U.S. Department of Health and Human Services (HHS), Department of Labor (DoL), and Department of the Treasury jointly issued guidance clarifying “protections for birth control coverage under the Affordable Care Act (ACA, Pub. L. 111-148).” Announcing the guidance, …
Recent HHS, Labor and Treasury Departments Guidance on ACA Birth Control Coverage Read more »
